Some women benefit from resuming GLP-1 therapy after delivery, particularly if breastfeeding is not planned, allowing you to regain momentum on your long-term health goals
The most commonly prescribed GLP-1 agonist is semaglutide, which has gained popularity in recent years after the Food and Drug Administration (FDA) approved it for the treatment of diabetes in 2017 (under the brand name Ozempic), for the treatment of obesity in 2021 (under the brand name Wegovy), and for reducing cardiovascular disease risk in 2024 (Wegovy)
3 Incidence and prevalence of PPH Different studies have reported widely varying incidence rates for PPH, ranging from 10% to 72%
When prescribed in an internal medicine setting, this medication serves a dual purpose: treating obesity while simultaneously correcting metabolic dysfunction, thereby offering a comprehensive approach to preventing future chronic disease
The Pathophysiology of Fibromyalgia: An Overview Fibromyalgia is a chronic syndrome with a multifactorial pathophysiological basis, the aetiology of which is not yet fully understood [1]
Fourth, predictive biomarkers capable of reliably stratifying patients for immunotherapy and targeted treatments remain suboptimal, contributing to treatment variability and overtreatment in many cases (329)